172 related articles for article (PubMed ID: 38085571)
1. Visualizing cancer-originating acetate uptake through monocarboxylate transporter 1 in reactive astrocytes in the glioblastoma tumor microenvironment.
Kim D; Ko HY; Chung JI; Park YM; Lee S; Kim SY; Kim J; Chun JH; Han KS; Lee M; Ju YH; Park SJ; Park KD; Nam MH; Kim SH; Shim JK; Park Y; Lim H; Park J; Lee GH; Kim H; Kim S; Park U; Ryu H; Lee SY; Park S; Kang SG; Chang JH; Lee CJ; Yun M
Neuro Oncol; 2024 May; 26(5):843-857. PubMed ID: 38085571
[TBL] [Abstract][Full Text] [Related]
2. Visualizing reactive astrocyte-neuron interaction in Alzheimer's disease using 11C-acetate and 18F-FDG.
Nam MH; Ko HY; Kim D; Lee S; Park YM; Hyeon SJ; Won W; Chung JI; Kim SY; Jo HH; Oh KT; Han YE; Lee GH; Ju YH; Lee H; Kim H; Heo J; Bhalla M; Kim KJ; Kwon J; Stein TD; Kong M; Lee H; Lee SE; Oh SJ; Chun JH; Park MA; Park KD; Ryu H; Yun M; Lee CJ
Brain; 2023 Jul; 146(7):2957-2974. PubMed ID: 37062541
[TBL] [Abstract][Full Text] [Related]
3. Regulation of Acetate Utilization by Monocarboxylate Transporter 1 (MCT1) in Hepatocellular Carcinoma (HCC).
Jeon JY; Lee M; Whang SH; Kim JW; Cho A; Yun M
Oncol Res; 2018 Jan; 26(1):71-81. PubMed ID: 28390113
[TBL] [Abstract][Full Text] [Related]
4. Tryptophan PET predicts spatial and temporal patterns of post-treatment glioblastoma progression detected by contrast-enhanced MRI.
Bosnyák E; Kamson DO; Robinette NL; Barger GR; Mittal S; Juhász C
J Neurooncol; 2016 Jan; 126(2):317-25. PubMed ID: 26514361
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas.
Miranda-Gonçalves V; Granja S; Martinho O; Honavar M; Pojo M; Costa BM; Pires MM; Pinheiro C; Cordeiro M; Bebiano G; Costa P; Reis RM; Baltazar F
Oncotarget; 2016 Jul; 7(29):46335-46353. PubMed ID: 27331625
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral Distribution of Lactate and the Monocarboxylate Transporters 1 and 4 in Human Glioblastoma Multiforme and Their Relationships to Tumor Progression-Associated Markers.
Kubelt C; Peters S; Ahmeti H; Huhndorf M; Huber L; Cohrs G; Hövener JB; Jansen O; Synowitz M; Held-Feindt J
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872409
[TBL] [Abstract][Full Text] [Related]
7. Clinical application of MAO-B PET using
Ishibashi K
Geriatr Gerontol Int; 2024 Mar; 24 Suppl 1():31-43. PubMed ID: 37973072
[TBL] [Abstract][Full Text] [Related]
8. Development of Novel Analogs of the Monocarboxylate Transporter Ligand FACH and Biological Validation of One Potential Radiotracer for Positron Emission Tomography (PET) Imaging.
Sadeghzadeh M; Wenzel B; Gündel D; Deuther-Conrad W; Toussaint M; Moldovan RP; Fischer S; Ludwig FA; Teodoro R; Jonnalagadda S; Jonnalagadda SK; Schüürmann G; Mereddy VR; Drewes LR; Brust P
Molecules; 2020 May; 25(10):. PubMed ID: 32423056
[TBL] [Abstract][Full Text] [Related]
9. Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets.
Miranda-Gonçalves V; Honavar M; Pinheiro C; Martinho O; Pires MM; Pinheiro C; Cordeiro M; Bebiano G; Costa P; Palmeirim I; Reis RM; Baltazar F
Neuro Oncol; 2013 Feb; 15(2):172-88. PubMed ID: 23258846
[TBL] [Abstract][Full Text] [Related]
10. Hodgkin lymphoma: A complex metabolic ecosystem with glycolytic reprogramming of the tumor microenvironment.
Mikkilineni L; Whitaker-Menezes D; Domingo-Vidal M; Sprandio J; Avena P; Cotzia P; Dulau-Florea A; Gong J; Uppal G; Zhan T; Leiby B; Lin Z; Pro B; Sotgia F; Lisanti MP; Martinez-Outschoorn U
Semin Oncol; 2017 Jun; 44(3):218-225. PubMed ID: 29248133
[TBL] [Abstract][Full Text] [Related]
11. GDNF mediates glioblastoma-induced microglia attraction but not astrogliosis.
Ku MC; Wolf SA; Respondek D; Matyash V; Pohlmann A; Waiczies S; Waiczies H; Niendorf T; Synowitz M; Glass R; Kettenmann H
Acta Neuropathol; 2013 Apr; 125(4):609-20. PubMed ID: 23344256
[TBL] [Abstract][Full Text] [Related]
12. [
Ballweg A; Klaus C; Vogler L; Katzdobler S; Wind K; Zatcepin A; Ziegler SI; Secgin B; Eckenweber F; Bohr B; Bernhardt A; Fietzek U; Rauchmann BS; Stoecklein S; Quach S; Beyer L; Scheifele M; Simmet M; Joseph E; Lindner S; Berg I; Koglin N; Mueller A; Stephens AW; Bartenstein P; Tonn JC; Albert NL; Kümpfel T; Kerschensteiner M; Perneczky R; Levin J; Paeger L; Herms J; Brendel M
J Neuroinflammation; 2023 Mar; 20(1):68. PubMed ID: 36906584
[TBL] [Abstract][Full Text] [Related]
13. Increased
Koyasu S; Shimizu Y; Morinibu A; Saga T; Nakamoto Y; Togashi K; Harada H
J Neurooncol; 2019 Dec; 145(3):441-447. PubMed ID: 31667733
[TBL] [Abstract][Full Text] [Related]
14. IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET/CT.
Röhrich M; Loktev A; Wefers AK; Altmann A; Paech D; Adeberg S; Windisch P; Hielscher T; Flechsig P; Floca R; Leitz D; Schuster JP; Huber PE; Debus J; von Deimling A; Lindner T; Haberkorn U
Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2569-2580. PubMed ID: 31388723
[TBL] [Abstract][Full Text] [Related]
15. Comparative In Vitro Study of
Vasilskis E; Kreimerman I; Olivera S; Savio E; Engler H
Cancer Biother Radiopharm; 2017 Nov; 32(9):344-350. PubMed ID: 29140741
[TBL] [Abstract][Full Text] [Related]
16. 11 C-Acetate PET/CT Detects Reactive Astrogliosis Helping Glioma Classification.
Kim D; Chun JH; Yi JH; Ko HY; Chung JI; Lee M; Park YM; Nam MH; Kim J; Kim SY; Park Y; Moon JH; Kang SG; Chang JH; Lee CJ; Kim SH; Yun M
Clin Nucl Med; 2022 Oct; 47(10):863-868. PubMed ID: 35868002
[TBL] [Abstract][Full Text] [Related]
17. The Value of 5-Aminolevulinic Acid in Low-grade Gliomas and High-grade Gliomas Lacking Glioblastoma Imaging Features: An Analysis Based on Fluorescence, Magnetic Resonance Imaging, 18F-Fluoroethyl Tyrosine Positron Emission Tomography, and Tumor Molecular Factors.
Jaber M; Wölfer J; Ewelt C; Holling M; Hasselblatt M; Niederstadt T; Zoubi T; Weckesser M; Stummer W
Neurosurgery; 2016 Mar; 78(3):401-11; discussion 411. PubMed ID: 26366972
[TBL] [Abstract][Full Text] [Related]
18. Correlation of Dynamic O-(2-[
Lohmann P; Piroth MD; Sellhaus B; Weis J; Geisler S; Oros-Peusquens AM; Mohlberg H; Amunts K; Shah NJ; Galldiks N; Langen KJ
World Neurosurg; 2018 Nov; 119():e653-e660. PubMed ID: 30077752
[TBL] [Abstract][Full Text] [Related]
19. Multimodal imaging-defined subregions in newly diagnosed glioblastoma: impact on overall survival.
John F; Bosnyák E; Robinette NL; Amit-Yousif AJ; Barger GR; Shah KD; Michelhaugh SK; Klinger NV; Mittal S; Juhász C
Neuro Oncol; 2019 Feb; 21(2):264-273. PubMed ID: 30346623
[TBL] [Abstract][Full Text] [Related]
20. Correlation of biological aggressiveness assessed by 11C-methionine PET and hypoxic burden assessed by 18F-fluoromisonidazole PET in newly diagnosed glioblastoma.
Kawai N; Maeda Y; Kudomi N; Miyake K; Okada M; Yamamoto Y; Nishiyama Y; Tamiya T
Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):441-50. PubMed ID: 21072512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
